EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Mitochondrial “swap” in the Tumor Microenvironment
Professor, Okayama University
Yosuke Togashi MD PhD is a Professor at Okayama University specializing in tumor microenvironment research He trained in respiratory medicine earned his PhD in genome biology and began cancer immunology research in
Articles
The Use of AI in Pharmacovigilance
Regulatory authorities RAs across the world are showing increased interest in the use and applications of artificial intelligence AI in pharmacovigilance PV At the same time these new cognitive technologies have generated concerns in the regulatory space public health and the life sciences industry RAs from different regions are focusing their efforts on developing standards and good practices for...
Research Insights
Knowledge integration using product R&D outsourcing in biotechnology
Abstract We build on systems integration literature to explain how and why knowledge integration of nonmodular products is based on a strategic choice between internalizing and outsourcing core RD The underresearched choice of outsourcing core RD on an ongoing basis appears to face risks of higher transactions costs and loss of control We illumina
Case Studies
Local Production Of Pharmaceuticals And Related Technology Transfer In Developing Countries
Abstract As stakeholders in the Global Strategy and Plan of Action on Public Health Innovation and Intellectual Property GSPAPHI adopted by the World Health Assembly in the United Nations Conference on Trade and Development UNCTAD the World Health Organization WHO and the International Centre for Trade and Sustainable Development ICTSD are col
Techno Trends
A 3D-Printed Clinical Device Intended to Detect Biomarkers of Preterm Birth
The DPrinted device is a microchip electrophoresis device that can sensitively detect three serum biomarkers of Preterm birth PTB
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
The Regulatory Landscape for Nutraceuticals
Suresh Garg is the CMD and Founder of Zeon Life Sciences. He has over 30 years of extensive experience in the fields of nutrition, dairy products, healthcare, and nutraceuticals. Under his leadership, Zeon has become a pioneer in contract manufacturing for nutraceuticals and herbal goods. Owing to his passion and ability to thrive in a variety of sociocultural environments, Zeon has entered international markets.
Tiny Vesicles, Big Impact
Dr. Disha Marwaha received her PhD in biological sciences from CSIR-Central Drug Research Institute (CSIR-CDRI), India in 2024. She is currently an Assistant Professor at the GLA University, Mathura. She has more than 20 publications in international peer-reviewed Journals. She is an expert in formulation and development, nanomedicine and pharmacokinetics focusing on innovative therapeutic and targeted drug delivery systems.
Dr. Neha Singh received her Ph.D. in Biological Sciences from the CSIR-Central Drug Research Institute (CSIR-CDRI), India, in 2025. She is currently an Assistant Professor at the Lloyd School of Pharmacy, Greater Noida. Dr. Singh has contributed extensively to the field of pharmaceutical sciences, with many publications, patents, and book chapters in internationally recognised peer-reviewed journals. Her primary research interests include formulation development, nanomedicine and pharmacokinetics, with a focus on innovative therapeutic strategies and targeted drug delivery systems. Dr. Singh’s work reflects her commitment to advancing precision medicine and developing next-generation solutions for healthcare.
Government Investment in AI Capabilities will Cement Singapore’s Position as a Premier Clinical Trial Location
Edwin Ng joined Medidata in 2014 and heads the Life Science industry of Dassault Systemes across the Asia Pacific region. Under his leadership, the company’s regional business recorded significant year-on-year growth and achieved multiple leadership awards. Edwin has spent the last 27 years of his career managing enterprise solutions businesses.
Therapeutic Peptides
Rienzi Mosqueda is a dedicated writer specialising in life science, health, and pharma content. With a passion for clear, engaging writing, Rienzi provides fresh perspectives on each topic. His ability to simplify complex ideas makes the articles valuable for readers of all backgrounds. As an emerging voice, Rienzi Mosqueda is committed to sharing knowledge and sparking discussions through their impactful writing.
Nanomedicine
Vinoth-Kumar Lakshmanan is a Senior Investigator and Professor for Prostate Cancer Biomarker Laboratory, Faculty of Clinical Research at Sri Ramachandra Institute of Higher Education and Research (DU), India and Adjunct Professor of Faculty of Engineering and Architectural Science, Toronto Metropolitan University, Canada. Vinoth has 20+ years’ experience in cancer biology. Scientific H Index 33 achieved with 4500 plus citations. He obtained Ph.D from University of Strasbourg, France, Post Doctoral from University of Regensburg and Karlsruhe Institute of Technology (KIT), Germany.
press releasesRead more...
Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
The Ministry of Health Labour and Welfare in Japan has granted approval for Sarclisa isatuximab subcutaneous SC formulation in combination with approved standardofcare regimens for the treatment of multiple myeloma
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Incyte Biosciences Japan GK today announced that Japans Ministry of Health Labour and Welfare MHLW has approved Minjuvi tafasitamab in combination with lenalidomide for the treatment of adults
Samsung Bioepis and Organon Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
Samsung Bioepis and Organon a global healthcare company with a deep expertise in biosimilars announced the expansion of their development and commercialization agreement whereby Organon will obtain commercialization
Chai Discovery Collaborates with Lilly TuneLab to Offer AI Capabilities to Select Biotechs
Chai Discovery the AI company engineering models to discover new molecules today announced that certain Chai Discovery frontier AI model capabilities will be made available to companies participating in the Lilly TuneLab platform
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
Charles River Laboratories International Inc NYSE CRL announced a collaboration with Lilly TuneLab a collaborative AIML drug discovery platform created by Eli Lilly and Company Lilly
Cold Chain Technologies Launches CCT Rx Secure to Streamline Specialty Pharmacy Shipments
Cold Chain Technologies has launched CCT Rx Secure a new digital application designed to support specialty pharmacies in making more informed repeatable packout decisions for temperaturesensitive shipments
EventsRead more...
23 - 24
Jun 2026Supply Chain USA 2026
Chicago, IL
24 - 25
Jun 20266th Edition Drug Safety Symposium 2026
Courtyard by Marriott, Mumbai,...
25 - 26
Jun 2026Pharmacology and Toxicology 2026
Paris, France
07 - 09
Jul 2026The Pharma India Expo 2026
Bombay Exhibition Centre, Mumb...
07 - 09
Jul 2026Nanosciences and Nanotechnologies 2026
Thessaloniki, Greece
08 - 10
Jul 2026CPHI SEA 2026
QSNCC, Bangkok, Thailand
09 - 11
Jul 2026Pharma Pro&Pack Expo 2026
HITEX Exhibition Centre, Hyder...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
LATEST NEWSRead more...
Greenstone Biosciences and Intel Partner to Advance AI-Driven Drug Discovery
Greenstone Biosciences Inc has entered into a strategic collaboration with Intel Corporation to accelerate AIenabled drug discovery by combining Greenstones largescale human induced pluripotent stem cell iPSC biobank with Intels advanced AI and computing infrastructure
SK pharmteco Partners with OTXL to Advance Rare Disease Therapies
SK pharmteco has entered into a strategic collaboration with the Orphan Therapeutics Accelerator OTXL to support the development and manufacturing of treatments for rare diseases
Boltz Collaborates with Takeda to Expand Use of Biomolecular AI Models in Drug Discovery
Boltz PBC has announced a collaboration with Takeda to deploy its advanced biomolecular artificial intelligence models and platform across Takedas research organisation
Insilico Reaches First Clinical Milestone for AI-Developed NLRP3 Inhibitor ISM8969
Insilico Medicine has completed firstinhuman dosing in the Phase I clinical study of ISM marking the first clinical milestone in its codevelopment partnership with Hygtia Therapeutics ISM is an orally administered
Biogen to Acquire RayThera to Strengthen Immunology Pipeline
Biogen has entered into a definitive agreement to acquire RayThera Inc a privately held biotechnology company focused on developing smallmolecule therapies for immunological diseases The deal is valued at up to billion
Jazz Pharmaceuticals and AbCellera Partner to Develop Next-Generation T-Cell Engaging Antibodies for Cancer
Jazz Pharmaceuticals and AbCellera have entered into a preclinical research collaboration option and licence agreement to discover and develop nextgeneration Tcell engaging TCE multispecific antibodies for gastrointestinal GI cancers and other solid tumours